BOT 0.00% 23.5¢ botanix pharmaceuticals ltd

"It's interesting to see that although we are not significantly...

  1. 233 Posts.
    lightbulb Created with Sketch. 220
    "It's interesting to see that although we are not significantly more effective at reducing lesion count,we are very competitive relative to other marketed and FDA approved products at current."

    This sentence puzzles me.
    I take it to mean that BTX1503 is shown to be better than leading FDA approved topicals but not 'significantly' so - because it just happens to outperform EPIDUO by 5 percentage points and ACZONE by 9 percentage points. (?)
    Do you think that 10 percentage points would be significant?

    Last edited by vitruvius: 20/08/19
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $226.6M
Open High Low Value Volume
24.0¢ 24.0¢ 23.5¢ $321.8K 1.351M

Buyers (Bids)

No. Vol. Price($)
18 1003482 23.5¢

Sellers (Offers)

Price($) Vol. No.
24.0¢ 571131 7
View Market Depth
Last update - 16.10pm 20/09/2019 (20 minute delay) ?
0.000 ( 0.97 %)
Open High Low Volume
24.0¢ 24.5¢ 23.5¢ 781714
Last updated 15.56pm 20/09/2019 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.